Bio-Connect

GALR1 antibody [C2C3], C-term

GTX108207
GeneTex
ApplicationsImmunoFluorescence, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetGALR1
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    GALR1 antibody [C2C3], C-term
  • Delivery Days Customer
    9
  • Application Supplier Note
    IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.3 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID2587
  • Target name
    GALR1
  • Target description
    galanin receptor 1
  • Target synonyms
    GALNR, GALNR1, galanin receptor type 1, GAL1-R, GALR-1
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP47211
  • Protein Name
    Galanin receptor type 1
  • Scientific Description
    The neuropeptide galanin elicits a range of biological effects by interaction with specific G-protein-coupled receptors. Galanin receptors are seven-transmembrane proteins shown to activate a variety of intracellular second-messenger pathways. GALR1 inhibits adenylyl cyclase via a G protein of the Gi/Go family. GALR1 is widely expressed in the brain and spinal cord, as well as in peripheral sites such as the small intestine and heart. [provided by RefSeq]
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Kiezun J, Kiezun M, Krazinski BE, et al. Galanin Receptors (GALR1, GALR2, and GALR3) Immunoexpression in Enteric Plexuses of Colorectal Cancer Patients: Correlation with the Clinico-Pathological Parameters. Biomolecules. 2022,12(12). doi: 10.3390/biom12121769
    Read this paper
  • Kiezun J, Godlewski J, Krazinski BE, et al. Galanin Receptors (GalR1, GalR2, and GalR3) Expression in Colorectal Cancer Tissue and Correlations to the Overall Survival and Poor Prognosis of CRC Patients. Int J Mol Sci. 2022,23(7). doi: 10.3390/ijms23073735
    Read this paper
  • Ma W, Lyu H, Pandya M, et al. Successful Application of a Galanin-Coated Scaffold for Periodontal Regeneration. J Dent Res. 2021,100(10):1144-1152. doi: 10.1177/00220345211028852
    Read this paper
  • Brunner SM, Reichmann F, Leitner J, et al. Galanin receptor 3 attenuates inflammation and influences the gut microbiota in an experimental murine colitis model. Sci Rep. 2021,11(1):564. doi: 10.1038/s41598-020-79456-y
    Read this paper
  • Falkenstetter S, Leitner J, Brunner SM, et al. Galanin System in Human Glioma and Pituitary Adenoma. Front Endocrinol (Lausanne). 2020,11:155. doi: 10.3389/fendo.2020.00155
    Read this paper
  • Koller A, Brunner SM, Bianchini R, et al. Galanin is a potent modulator of cytokine and chemokine expression in human macrophages. Sci Rep. 2019,9(1):7237. doi: 10.1038/s41598-019-43704-7
    Read this paper
  • Schrödl F, Kaser-Eichberger A, Trost A, et al. Distribution of galanin receptors in the human eye. Exp Eye Res. 2015,138:42-51. doi: 10.1016/j.exer.2015.06.024
    Read this paper